WT1 expression distinguishes astrocytic tumor cells from normal and reactive astrocytes

Brain Pathology

Volumn 18, Issue 3, 2008, Pages 344-353

  Schittenhelm, Jens ^a,b   Mittelbronn, Michel ^b   Nguyen, Thai Dung ^b   Meyermann, Richard ^b   Beschorner, Rudi ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Astrocytoma; Astrogliosis; Neoplastic astrocytes; Normal brain; WT1

Indexed keywords

WT1 PROTEIN;

ARTICLE; ASTROCYTE; ASTROCYTOMA; ASTROCYTOMA CELL; ASTROCYTOSIS; BRAIN BIOPSY; CANCER GRADING; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METHODOLOGY; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ASTROCYTES; ASTROCYTOMA; BRAIN NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; GLIOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 44649105059     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2008.00127.x     Document Type: Article

References (57)

1. Agapova OA, Ricard CS, Salvador-Silva M, Yang P, Hernandez MR (2001) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 33 : 205 216.
2. Aldape KD, Ballman K, Furth A, Buckner JC, Giannini C, Burger PC et al (2004) Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. J Neuropathol Exp Neurol 63 : 700 707.
3. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB (1993) The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev 40 : 85 97.
4. Asano K, Kubo O, Tajika Y, Huang MC, Takakura K, Ebina K, Suzuki S (1997) Expression and role of cadherins in astrocytic tumors. Brain Tumor Pathol 14 : 27 33.
5. Aschner M, Sonnewald U, Tan KH (2002) Astrocyte modulation of neurotoxic injury. Brain Pathol 12 : 475 481.
6. Asemissen AM, Keilholz U, Tenzer S, Müller M, Walter S, Stevanovic S et al (2006) Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1. Clin Cancer Res 12 : 7476 7482.
7. Biernat W, Huang H, Yokoo H, Kleihues P, Ohgaki H (2004) Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas. Brain Pathol 14 : 131 136.
8. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE (1991) Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol 11 : 1707 1712.
9. Burger PC, Scheithauer BW, Vogel FS (2002) The brain - tumors. In : Surgical Pathology of the Nervous System and Its Coverings, 4th edn. PC Burger, FC Vogel (eds), pp. 160 378. Elsevier : Oxford.
10. von Deimling A, Burger PC, Nakazato Y, Ohgaki H, Kleihues P (2007) Diffuse astrocytoma. In : WHO Classification of Tumours: Pathology and Genetics: Tumours of the Nervous System. DN Louis, H Ohgaki, OD Wiestler, WK Cavenee (eds), pp. 25 29. International Agency for Research on Cancer : Lyon.
11. Eddleston M, Mucke L (1993) Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 54 : 15 36.
12. Eng LF, Ghirnikar RS (1994) GFAP and astrogliosis. Brain Pathol 4 : 229 237.
13. Ellison D, Love S, Chimelli L, Harding BN, Lowe J, Vinters HV (2004) Neuropathology - A Reference Text of CNS Pathology, 2nd edn. Mosby : London.
14. Forsyth RJ (1996) Astrocytes and the delivery of glucose from plasma to neurons. Neurochem Int 28 : 231 241.
15. Gaudin PB, Sherman ME, Brat DJ, Zahurak M, Erozan YS (1997) Accuracy of grading gliomas on CT-guided stereotactic biopsies: a survival analysis. Diagn Cytopathol 17 : 461 466.
16. Giaume C, Venance L (1998) Intercellular calcium signaling and gap junctional communication in astrocytes. Glia 24 : 50 64.
17. Graham K, Li W, Williams BR, Fraizer G (2006) Vascular endothelial growth factor (VEGF) is suppressed in WT1-transfected LNCaP cells. Gene Expr 13 : 1 14.
18. Hanson J, Gorman J, Reese J, Fraizer G (2007) Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci 12 : 2279 2290.
19. Hashiba T, Izumoto S, Kagawa N, Suzuki T, Hashimoto N, Maruno M, Yoshimine T (2007) Expression of WT1 protein and correlation with cellular proliferation in glial tumors. Neurol Med Chir 47 : 165 170.
20. Hastie ND (1994) The genetics of Wilms' tumor - a case of disrupted development. Annu Rev Genet 28 : 523 558.
21. Junier MP (2000) What role(s) for TGFalpha in the central nervous system? Prog Neurobiol 62 : 443 473.
22. Kerr JF, Winterford CM, Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73 : 2013 2026.
23. Kishima H, Shimizu K, Tamura K, Miyao Y, Mabuchi E, Tominaga E et al (1999) Monoclonal antibody ONS-M21 recognizes integrin alpha3 in gliomas and medulloblastomas. Br J Cancer 79 : 333 339.
24. Kumar-Singh S, Segers K, Rodeck U, Backhovens H, Bogers J, Weyler J et al (1997) WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis. J Pathol 181 : 67 74.
25. Kuppner MC, Van Meir E, Gauthier T, Hamou MF, de Tribolet N (1992) Differential expression of the CD44 molecule in human brain tumours. Int J Cancer 50 : 572 577.
26. Kurtkaya-Yapicier O, Scheithauer BW, Hebrink D, James CD (2002) p53 in nonneoplastic central nervous system lesions: an immunohistochemical and genetic sequencing study. Neurosurgery 51 : 1246 1254.
27. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33 : 159 174.
28. Lawley LP, Cerimele F, Weiss SW, North P, Cohen C, Kozakewich HP et al (2005) Expression of Wilms' tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. Arch Dermatol 141 : 1297 1300.
29. Lieska N, Yang HY, Goldman RD (1985) Purification of the 300K intermediate filament-associated protein and its in vitro recombination with intermediate filaments. J Cell Biol 101 : 802 813.
30. Liu B, Chen H, Johns TG, Neufeld AH (2006) Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J Neurosci 26 : 7532 7540.
31. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher FJ 3rd., Hill DE, Haber DA (1993) Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 90 : 5100 5104.
32. Menssen HD, Bertelmann E, Bartelt S, Schmidt RA, Pecher G, Schramm K, Thiel E (2000) Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens. J Cancer Res Clin Oncol 126 : 226 232.
33. Modak S, Kramer K, Gultekin SH, Guo HF, Cheung NK (2001) Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors. Cancer Res 61 : 4048 4054.
34. Monod L, Hamou MF, Ronco P, Verroust P, de Tribolet N (1992) Expression of cALLa/NEP on gliomas: a possible marker of malignancy. Acta Neurochir 114 : 3 7.
35. Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE, Morrison RS (1995) Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 82 : 858 863.
36. Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T et al (2006) Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 19 : 804 814.
37. Niksic M, Slight J, Sanford JR, Caceres JF, Hastie ND (2004) The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 13 : 463 471.
38. Norenberg MD (1994) Astrocyte responses to CNS injury. J Neuropathol Exp Neurol 53 : 213 220.
39. Oji Y, Suzuki T, Nakano Y, Maruno M, Nakatsuka S, Jomgeow T et al (2004) Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors. Cancer Sci 95 : 822 827.
40. Onda M, Wang QC, Guo HF, Cheung NK, Pastan I (2004) In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma. Cancer Res 64 : 1419 1424.
41. Planas AM, Justicia C, Soriano MA, Ferrer I (1998) Epidermal growth factor receptor in proliferating reactive glia following transient focal ischemia in the rat brain. Glia 23 : 120 129.
42. Prayson RA, Agamanolis DP, Cohen ML, Estes ML, Kleinschmidt-DeMasters BK, Abdul-Karim F et al (2000) Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci 175 : 33 39.
43. Rasheed BK, Bigner SH (1991) Genetic alterations in glioma and medulloblastoma. Cancer Metastasis Rev 10 : 289 299.
44. Redies C (2000) Cadherins in the central nervous system. Prog Neurobiol 61 : 611 648.
45. Rust RS (1994) Energy metabolism of developing brain. Curr Opin Neurol 7 : 160 165.
46. Scharnhorst V, Kranenburg O, van der Eb AJ, Jochemsen AG (1997) Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells. Cell Growth Differ 8 : 133 143.
47. Timár J, Mészáros L, Orosz Z, Albini A, Rásó E (2005) WT1 expression in angiogenic tumours of the skin. Histopathology 47 : 67 73.
48. Wagner KD, Wagner N, Wellmann S, Schley G, Bondke A, Theres H, Scholz H (2003) Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J 17 : 1364 1366.
49. Waxman SG, Sontheimer H, Black JA, Minturn JE, Ransom BR (1993) Dynamic aspects of sodium channel expression in astrocytes. Adv Neurol 59 : 135 155.
50. Wessels PH, Hopman AH, Ummelen MI, Krijne-Kubat B, Ramaekers FC, Twijnstra A (2001) Differentiation between reactive gliosis and diffuse astrocytoma by in situ hybridization. Neurology 56 : 1224 1227.
51. Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humphrey PA, Kurpad SN et al (1995) Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res 55 : 3140 3148.
52. Yamada T, Kawamata T, Walker DG, McGeer PL (1992) Vimentin immunoreactivity in normal and pathological human brain tissue. Acta Neuropathol 84 : 157 162.
53. Yang HY, Lieska N, Glick R, Shao D, Pappas GD (1993) Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes. Proc Natl Acad Sci USA 90 : 8534 8537.
54. Yaziji H, Massarani-Wafai R, Gujrati M, Kuhns JG, Martin AW, Parker JC (1996) Role of p53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesions. Am J Surg Pathol 20 : 1086 1090.
55. Yung WK, Luna M, Borit A (1985) Vimentin and glial fibrillary acidic protein in human brain tumors. J Neurooncol 3 : 35 38.
56. Zagzag D, Miller DC, Kleinman GM, Abati A, Donnenfeld H, Budzilovich GN (1993) Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol 17 : 537 545.
57. Zeltner L, Schittenhelm J, Mittelbronn M, Roser F, Tatagiba M, Mawrin C et al (2007) The astrocytic response towards invasive meningiomas. Neuropathol Appl Neurobiol 33 : 163 168.